• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化固体脂质纳米粒(SLN)合成条件。

Optimization of the Conditions of Solid Lipid Nanoparticles (SLN) Synthesis.

机构信息

Faculty of Chemistry, Adam Mickiewicz University, 8: Uniwersytetu Poznańskiego, 61-614 Poznan, Poland.

出版信息

Molecules. 2022 Mar 28;27(7):2202. doi: 10.3390/molecules27072202.

DOI:10.3390/molecules27072202
PMID:35408600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9000502/
Abstract

Solid lipid nanoparticles (SLNs) have been synthesized as potential drug delivery systems. They are classified as solid lipid nanocarriers that can successfully carry both hydrophilic and hydrophobic drugs. SLNs are based on a biocompatible lipid matrix that is enzymatically degraded into natural components found in the human body. Solid lipid nanoparticles are suitable for the incorporation of hydrophobic active ingredients such as curcumin. The study included the optimization of lipid nanoparticle composition, incorporation of the active compound (curcumin), a stability evaluation of the obtained nanocarriers and characterization of their lipid matrix. Through process optimization, a dispersion of solid lipid nanoparticles (solid lipid:surfactant—2:1.25 weight ratio) predisposed to the incorporation of curcumin was developed. The encapsulation efficiency of the active ingredient was determined to be 99.80%. In stability studies, it was found that the most suitable conditions for conducting high-pressure homogenization are 300 bar pressure, three cycles and a closed-loop system. This yields the required values of the physicochemical parameters (a particle size within a 200−450 nm range; a polydispersity index of <30%; and a zeta potential of about |±30 mV|). In this work, closed-loop high-pressure homogenization was used for the first time and compared to the currently preferred open-loop method.

摘要

固体脂质纳米粒(SLNs)已被合成作为潜在的药物传递系统。它们被归类为固体脂质纳米载体,可以成功携带亲水性和疏水性药物。SLNs 基于生物相容性脂质基质,该基质可被酶解为人体内存在的天然成分。固体脂质纳米粒适合包封疏水性活性成分,如姜黄素。本研究包括优化脂质纳米粒的组成、包封活性化合物(姜黄素)、对获得的纳米载体进行稳定性评估以及对其脂质基质进行表征。通过工艺优化,开发了一种有利于包封姜黄素的固体脂质纳米粒分散体(固体脂质:表面活性剂-2:1.25 重量比)。活性成分的包封效率确定为 99.80%。在稳定性研究中,发现进行高压匀浆的最适条件为 300 巴压力、三个循环和闭环系统。这产生了所需的物理化学参数值(粒径在 200-450nm 范围内;多分散指数<30%;和约 |±30 mV| 的 ζ 电位)。在这项工作中,首次使用闭环高压匀浆并与目前优选的开环方法进行了比较。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ffd/9000502/7ab3e553db3f/molecules-27-02202-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ffd/9000502/b77985290f92/molecules-27-02202-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ffd/9000502/7a0adb45f5f5/molecules-27-02202-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ffd/9000502/8b23dedbd143/molecules-27-02202-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ffd/9000502/1df45f694c23/molecules-27-02202-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ffd/9000502/97814b89cc66/molecules-27-02202-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ffd/9000502/fb58f958db31/molecules-27-02202-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ffd/9000502/ac731aa91bd7/molecules-27-02202-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ffd/9000502/4daba624cbc8/molecules-27-02202-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ffd/9000502/7ab3e553db3f/molecules-27-02202-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ffd/9000502/b77985290f92/molecules-27-02202-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ffd/9000502/7a0adb45f5f5/molecules-27-02202-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ffd/9000502/8b23dedbd143/molecules-27-02202-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ffd/9000502/1df45f694c23/molecules-27-02202-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ffd/9000502/97814b89cc66/molecules-27-02202-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ffd/9000502/fb58f958db31/molecules-27-02202-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ffd/9000502/ac731aa91bd7/molecules-27-02202-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ffd/9000502/4daba624cbc8/molecules-27-02202-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ffd/9000502/7ab3e553db3f/molecules-27-02202-g008.jpg

相似文献

1
Optimization of the Conditions of Solid Lipid Nanoparticles (SLN) Synthesis.优化固体脂质纳米粒(SLN)合成条件。
Molecules. 2022 Mar 28;27(7):2202. doi: 10.3390/molecules27072202.
2
Solid Lipid Nanoparticles Incorporated with Retinol and Pentapeptide-18-Optimization, Characterization, and Cosmetic Application.含视黄醇和五肽-18 的固体脂质纳米粒的优化、表征和化妆品应用。
Int J Mol Sci. 2024 Sep 19;25(18):10078. doi: 10.3390/ijms251810078.
3
Characterization and stability of nanostructured lipid carriers as drug delivery system.纳米结构脂质载体作为药物递送系统的表征与稳定性
Pak J Biol Sci. 2012 Feb 1;15(3):141-6. doi: 10.3923/pjbs.2012.141.146.
4
Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.采用质量源于设计方法,以单硬脂酸甘油酯为单一脂质制备姜黄素固体脂质纳米粒:对人乳腺癌细胞系的抗癌活性表征与评价
Curr Drug Deliv. 2018;15(9):1271-1283. doi: 10.2174/1567201815666180503120113.
5
Physicochemical Characterization, Stability, and In Vitro Evaluation of Curcumin-Loaded Solid Lipid Nanoparticles Prepared Using Biocompatible Synthetic Lipids.采用生物相容性合成脂质制备姜黄素载固体脂质纳米粒的理化特性表征、稳定性及体外评价
ACS Appl Bio Mater. 2023 Jul 17;6(7):2785-2794. doi: 10.1021/acsabm.3c00252. Epub 2023 Jul 5.
6
Formulation of the novel structure curcumin derivative-loaded solid lipid nanoparticles: synthesis, optimization, characterization and anti-tumor activity screening .新型结构姜黄素衍生物载固体脂质纳米粒的制剂研究:合成、优化、表征及抗肿瘤活性筛选。
Drug Deliv. 2022 Dec;29(1):2044-2057. doi: 10.1080/10717544.2022.2092235.
7
Lipid Nanoparticles Loaded with Iridoid Glycosides: Development and Optimization Using Experimental Factorial Design.载有环烯醚萜苷的脂质纳米粒:使用实验析因设计进行开发和优化。
Molecules. 2021 May 25;26(11):3161. doi: 10.3390/molecules26113161.
8
Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.用于固体脂质纳米粒(SLN)制剂预筛选的 Hansen 溶解度参数(HSP):姜黄素负载的 SLN 在 MCF-7 和 BT-474 细胞系中的体外测试。
Pharm Dev Technol. 2018 Jan;23(1):96-105. doi: 10.1080/10837450.2017.1384491. Epub 2017 Oct 10.
9
Optimization of linalool-loaded solid lipid nanoparticles using experimental factorial design and long-term stability studies with a new centrifugal sedimentation method.采用实验因子设计优化芳樟醇固体脂质纳米粒及其新离心沉降法的长期稳定性研究。
Int J Pharm. 2018 Oct 5;549(1-2):261-270. doi: 10.1016/j.ijpharm.2018.07.068. Epub 2018 Jul 31.
10
Optimization and characterization of ultrasound assisted preparation of curcumin-loaded solid lipid nanoparticles: Application of central composite design, thermal analysis and X-ray diffraction techniques.超声辅助制备载姜黄素固体脂质纳米粒的优化及特性研究:中心组合设计、热分析和 X 射线衍射技术的应用。
Ultrason Sonochem. 2017 Sep;38:271-280. doi: 10.1016/j.ultsonch.2017.03.013. Epub 2017 Mar 8.

引用本文的文献

1
Enhanced lymphatic transportation of SLN by mimicking oligopeptide transportation route.通过模拟寡肽转运途径增强前哨淋巴结的淋巴转运。
Asian J Pharm Sci. 2025 Jun;20(3):101019. doi: 10.1016/j.ajps.2025.101019. Epub 2025 Jan 10.
2
Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape.临床视角下的纳米颗粒疗法:分类、上市产品及监管格局
Small. 2025 Jun 2:e2502315. doi: 10.1002/smll.202502315.
3
Nanoparticles and Nanomaterials: A Review from the Standpoint of Pharmacy and Medicine.

本文引用的文献

1
Loading, release profile and accelerated stability assessment of monoterpenes-loaded solid lipid nanoparticles (SLN).载药固体脂质纳米粒(SLN)的载药量、释放特性及加速稳定性评价。
Pharm Dev Technol. 2020 Sep;25(7):832-844. doi: 10.1080/10837450.2020.1744008. Epub 2020 Mar 23.
2
Preparation, Characterization, and In vitro Evaluation of Curcumin- and Resveratrol-Loaded Solid Lipid Nanoparticles.载姜黄素和白藜芦醇固体脂质纳米粒的制备、表征及体外评价。
AAPS PharmSciTech. 2019 Mar 18;20(4):145. doi: 10.1208/s12249-019-1349-4.
3
Nanotechnology in Wound Healing; Semisolid Dosage Forms Containing Curcumin-Ampicillin Solid Lipid Nanoparticles, , and Characteristics.
纳米颗粒与纳米材料:从药学与医学角度的综述
Pharmaceutics. 2025 May 16;17(5):655. doi: 10.3390/pharmaceutics17050655.
4
Preparation of surface-modified PLGA nanoparticles containing carbon quantum dots: insights from C6 cell line assays.含碳量子点的表面改性聚乳酸-羟基乙酸共聚物纳米颗粒的制备:来自C6细胞系检测的见解
Nanomedicine (Lond). 2025 Jun;20(12):1403-1416. doi: 10.1080/17435889.2025.2504322. Epub 2025 May 20.
5
Anticancer efficacy of dual-loaded SLNs with Doxorubicin (DOX) and Pterostilbene (PTS): formulation, characterization, and evaluation for breast cancer.载有阿霉素(DOX)和紫檀芪(PTS)的双负载纳米结构脂质载体的抗癌疗效:乳腺癌的制剂、表征及评价
Nanomedicine (Lond). 2025 Jun;20(11):1249-1265. doi: 10.1080/17435889.2025.2501526. Epub 2025 May 6.
6
An Experimental Design Approach for Producing Curcumin-Loaded Solid Lipid Nanoparticles.一种制备载姜黄素固体脂质纳米粒的实验设计方法。
Pharmaceuticals (Basel). 2025 Mar 27;18(4):470. doi: 10.3390/ph18040470.
7
Solid Lipid Nanoparticles for the Management of Hypertension: Advancements and Challenges.用于高血压治疗的固体脂质纳米粒:进展与挑战
Curr Pharm Des. 2025;31(23):1823-1843. doi: 10.2174/0113816128337166241219081400.
8
Targeting Acne: Development of Monensin-Loaded Nanostructured Lipid Carriers.靶向治疗痤疮:载莫能菌素纳米结构脂质载体的研发
Int J Nanomedicine. 2025 Feb 19;20:2181-2204. doi: 10.2147/IJN.S497108. eCollection 2025.
9
Development and Characterization of Lyophilized Chondroitin Sulfate-Loaded Solid Lipid Nanoparticles: Encapsulation Efficiency and Stability.冻干硫酸软骨素负载固体脂质纳米粒的研制与表征:包封率与稳定性
Pharmaceutics. 2025 Jan 10;17(1):86. doi: 10.3390/pharmaceutics17010086.
10
Assessment of the Photosynthetic Response of Potato Plants Inoculated with and Treated with Flesh-Colored Potato Extracts Nanoencapsulated with Solid Lipid Nanoparticles.对用固体脂质纳米粒纳米包封的肉色马铃薯提取物接种和处理的马铃薯植株光合响应的评估。
Plants (Basel). 2025 Jan 7;14(2):156. doi: 10.3390/plants14020156.
伤口愈合中的纳米技术;含姜黄素-氨苄西林固体脂质纳米粒的半固体剂型及其特性
Adv Pharm Bull. 2018 Aug;8(3):395-400. doi: 10.15171/apb.2018.046. Epub 2018 Aug 29.
4
Preparation and characterization of citral-loaded solid lipid nanoparticles.制备并表征载柠檬醛固体脂质纳米粒。
Food Chem. 2018 May 15;248:78-85. doi: 10.1016/j.foodchem.2017.11.091. Epub 2017 Nov 24.
5
Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery.超越脂质体:用于难溶性/难渗透性药物传递的基于脂质的纳米结构的最新进展。
Prog Lipid Res. 2017 Oct;68:1-11. doi: 10.1016/j.plipres.2017.07.001. Epub 2017 Aug 1.
6
Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation.固体脂质纳米粒和纳米结构脂质载体的临床前安全性:来自体外和体内评价的当前证据
Eur J Pharm Biopharm. 2016 Nov;108:235-252. doi: 10.1016/j.ejpb.2016.08.001. Epub 2016 Aug 9.
7
Discovery of a new function of curcumin which enhances its anticancer therapeutic potency.发现姜黄素的新功能,增强其抗癌治疗效力。
Sci Rep. 2016 Aug 1;6:30962. doi: 10.1038/srep30962.
8
DLS and zeta potential - What they are and what they are not?动态光散射(DLS)和 Zeta 电位:它们是什么,又不是什么?
J Control Release. 2016 Aug 10;235:337-351. doi: 10.1016/j.jconrel.2016.06.017. Epub 2016 Jun 10.
9
Optimization of solid lipid nanoparticles prepared by a single emulsification-solvent evaporation method.单乳化溶剂蒸发法制备固体脂质纳米粒的优化
Data Brief. 2015 Nov 25;6:15-9. doi: 10.1016/j.dib.2015.11.038. eCollection 2016 Mar.
10
Physicochemical characterization of epigallocatechin gallate lipid nanoparticles (EGCG-LNs) for ocular instillation.用于眼部滴注的表没食子儿茶素没食子酸酯脂质纳米粒(EGCG-LNs)的物理化学特性
Colloids Surf B Biointerfaces. 2014 Nov 1;123:452-60. doi: 10.1016/j.colsurfb.2014.09.042. Epub 2014 Sep 28.